3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
5
Multiple Myeloma
4
Lymphoma
3
Hematologic Neoplasms
3
Glioma
3
Pancreatic Neoplasms
2
Neurofibromatosis 1
2
Neoplasms
2
Glioblastoma
2
Astrocytoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Refractory Differentiated Thyroid Gland Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Juvenile
1
Histiocytosis, Langerhans-Cell
1
Ganglioneuroma
1
Ganglioglioma
1
Interventions
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
pembrolizumab
4
Platinum
4
Cisplatin
4
Biopsy
4
1,2-diaminocyclohexaneplatinum II citrate
4
Radiotherapy, Intensity-Modulated
3
Cetuximab
3
(225)Ac-DOTA-c(RGDyK)
3
ipatasertib
2
cemiplimab
2
Radiotherapy
2
Radiation
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
merphos
1
durvalumab
1
cabozantinib
1
atezolizumab
1
X-Rays
1
Transurethral Resection of Bladder
1
Taxes
1
Radiosurgery
1
Paclitaxel
1
Nivolumab
1
Methotrexate
1
Interviews as Topic
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
trametinib
×
30 days
×
Clear all
No trials found.